Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?

Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...

Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...

- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days - - Results to be presented at PSYCH Symposium taking...
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April. As we stated earlier, Revive Therapeutics (RVVTF)...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, April 11, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company...

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...

New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid. Early Bird Gets the Worm? Here's...
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE NEWS ARCHIVE INTRO “These medicines have a sweet spot. If the day you get diagnosed with COVID you...

Revive Therapeutics (RVVTF) Provides Update of Psilocybin Pharmaceutical Programs

IRB approval to initiate Phase 2 study for methamphetamine abuse disordersAdvancing psilocybin oral thin film, microneedle patch and biosynthesis programs TORONTO, Jan. 17, 2022 (GLOBE...

Ehave’s Mobile Ketamine Clinic, Rolling into Town.

Longer term, Ehave's (EHVVF) performance has been a quite a disappointment. Investors grew impatient for the launch of one of the most significant advances...

The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...

The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21. Revive Therapeutics (RVTTF), RedHill BioPharma (RDHL), AI Pharma (Private), Apilli Thera...
Psychedelic Stock Review

Coming This Monday..

Microdose's Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9, 2021. Wonderland: Miami Full...

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...